NEW YORK (360Dx) – The US Food and Drug Administration has granted 510(k) clearance for a line of clinical chemistry and immunoassay diagnostic instruments from Abbott, the firm announced today.

The Alinity c clinical chemistry system and Alinity i immunoassay system can be used individually or as an integrated Alinity ci-series unit, Abbott noted in a statement, adding the ci-series instruments have half the footprint of existing systems due to its stacked design.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.